These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31138938)

  • 1. Standards of aminoglycoside therapeutic drug monitoring in a South African private hospital: perspectives and implications.
    du Toit M; Burger JR; Rakumakoe DM; Rheeders M
    Ghana Med J; 2019 Mar; 53(1):8-12. PubMed ID: 31138938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Retrospective Review of the Efficiency of First-Dose Therapeutic Drug Monitoring of Gentamicin, Amikacin, and Vancomycin in the Pediatric Population.
    Lim WXS; Chua WBB; Chua JM; Lee Q; Chan JW; Sultana R; Poh BH
    J Clin Pharmacol; 2020 Jan; 60(1):7-15. PubMed ID: 31448430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interest of therapeutic drug monitoring of aminoglycosides administered by a monodose regimen.
    Ben Romdhane H; Ben Fredj N; Chaabane A; Ben Aicha S; Chadly Z; Ben Fadhel N; Boughattas N; Aouam K
    Nephrol Ther; 2019 Apr; 15(2):110-114. PubMed ID: 30660586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic drug monitoring of aminoglycosides in acute myeloid leukaemia patients.
    Mareville J; Gay J; Cliquennois E; Herbaux C; Pasquier F; Allorge D; Blondiaux N; Berthon C; Alfandari S
    Scand J Infect Dis; 2012 May; 44(5):398-401. PubMed ID: 22235869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma concentration and eGFR in preterm and term neonates receiving gentamicin or successive amikacin therapy.
    Singu BS; Ndeunyema MN; Ette EI; Pieper CH; Verbeeck RK
    BMC Pediatr; 2023 Jan; 23(1):24. PubMed ID: 36647065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the Relationship between FEV
    Hoff BM; Scheetz MH; Jain M; Cullina JF; Rhodes NJ
    Pharmacotherapy; 2020 Jun; 40(6):584-591. PubMed ID: 32259317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic drug monitoring of once daily aminoglycoside dosing: comparison of two methods and investigation of the optimal blood sampling strategy.
    Nezic L; Derungs A; Bruggisser M; Tschudin-Sutter S; Krähenbühl S; Haschke M
    Eur J Clin Pharmacol; 2014 Jul; 70(7):829-37. PubMed ID: 24756148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminoglycoside Dosing and Volume of Distribution in Critically Ill Surgery Patients.
    Grucz TM; Kruer RM; Bernice F; Lipsett PA; Dorman T; Sugrue D; Jarrell AS
    Surg Infect (Larchmt); 2020 Dec; 21(10):859-864. PubMed ID: 32302517
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetic dosing of aminoglycosides: a controlled trial.
    Bartal C; Danon A; Schlaeffer F; Reisenberg K; Alkan M; Smoliakov R; Sidi A; Almog Y
    Am J Med; 2003 Feb; 114(3):194-8. PubMed ID: 12637133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of aminoglycoside dosing and estimated glomerular filtration rate in determining gentamicin and tobramycin area under the curve and clearance.
    Lim AK; Mathanasenarajah G; Larmour I
    Intern Med J; 2015 Mar; 45(3):319-29. PubMed ID: 25581282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminoglycoside prescription, therapeutic monitoring and nephrotoxicity at a university hospital in Saudi Arabia.
    Eltahawy AT; Bahnassy AA
    J Chemother; 1996 Aug; 8(4):278-83. PubMed ID: 8873833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A meta-analysis of the target trough concentration of gentamicin and amikacin for reducing the risk of nephrotoxicity.
    Yamada T; Fujii S; Shigemi A; Takesue Y
    J Infect Chemother; 2021 Feb; 27(2):256-261. PubMed ID: 33077364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A survey of extended-interval aminoglycoside dosing practices in United States adult cystic fibrosis programs.
    Prescott WA
    Respir Care; 2014 Sep; 59(9):1353-9. PubMed ID: 24782555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin.
    Hermida J; Tutor JC
    Ther Drug Monit; 2006 Jun; 28(3):326-31. PubMed ID: 16778715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated Microfluidic Devices Fabricated in Poly (Methyl Methacrylate) (PMMA) for On-site Therapeutic Drug Monitoring of Aminoglycosides in Whole Blood.
    Al-Aqbi ZT; Yap YC; Li F; Breadmore MC
    Biosensors (Basel); 2019 Jan; 9(1):. PubMed ID: 30704056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monitoring aminoglycosides in an Intensive Care Unit].
    Commandeur D; Eyrieux S; Le Noël A; Nguyen VB; Giacardi C; Danguy des Déserts M; Buguet-Brown ML; Drouillard I
    Med Mal Infect; 2010 Feb; 40(2):94-9. PubMed ID: 19793633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aminoglycosides use in patients over 75 years old.
    Fraisse T; Gras Aygon C; Paccalin M; Vitrat V; De Wazieres B; Baudoux V; Lechiche C; Vicens A; Sotto A; Pagani L; Gaillat J; Forestier E; Gavazzi G
    Age Ageing; 2014 Sep; 43(5):676-81. PubMed ID: 24590569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of serum concentrations of some aminoglycoside antibiotics by use of the fluorescent immunoassay method.
    Dzierzanowska D; Nowik-Jurek M; Podleśny J
    Arch Immunol Ther Exp (Warsz); 1983; 31(3):389-94. PubMed ID: 6651487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic monitoring of amikacin and gentamicin in routine clinical practice].
    Kacířová I; Grundmann M
    Vnitr Lek; 2015 Jan; 61(1):33-41. PubMed ID: 25693614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choice of drug and dosage regimen. Two important risk factors for aminoglycoside nephrotoxicity.
    De Broe ME; Giuliano RA; Verpooten GA
    Am J Med; 1986 Jun; 80(6B):115-8. PubMed ID: 3728523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.